329.84
Schlusskurs vom Vortag:
$329.07
Offen:
$327.98
24-Stunden-Volumen:
134.86K
Relative Volume:
0.36
Marktkapitalisierung:
$36.17B
Einnahmen:
$3.81B
Nettoeinkommen (Verlust:
$-644.79M
KGV:
-52.86
EPS:
-6.24
Netto-Cashflow:
$-669.77M
1W Leistung:
-0.71%
1M Leistung:
+5.16%
6M Leistung:
+30.27%
1J Leistung:
+0.00%
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Firmenname
Beone Medicines Ltd Adr
Sektor
Branche
Telefon
41-616851900
Adresse
C/O BEONE MEDICINES I GMBH, BASEL
Vergleichen Sie ONC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-18 | Eingeleitet | Barclays | Overweight |
2025-04-07 | Eingeleitet | RBC Capital Mkts | Outperform |
2025-03-03 | Hochstufung | BofA Securities | Neutral → Buy |
2024-12-03 | Fortgesetzt | Morgan Stanley | Overweight |
2024-09-18 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-02-06 | Fortgesetzt | JP Morgan | Overweight |
2023-09-12 | Eingeleitet | Macquarie | Outperform |
2023-08-17 | Eingeleitet | Jefferies | Buy |
2023-07-17 | Eingeleitet | Citigroup | Buy |
2023-06-30 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2023-01-12 | Eingeleitet | Daiwa Securities | Buy |
2022-10-13 | Hochstufung | Guggenheim | Neutral → Buy |
2022-10-13 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2022-08-09 | Fortgesetzt | JP Morgan | Overweight |
2022-03-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-02-07 | Eingeleitet | Deutsche Bank | Buy |
2021-10-12 | Eingeleitet | Bernstein | Outperform |
2021-10-06 | Hochstufung | CLSA | Underperform → Buy |
2021-03-08 | Eingeleitet | China Renaissance | Buy |
2021-03-01 | Herabstufung | CLSA | Outperform → Underperform |
2020-11-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2020-11-06 | Herabstufung | Maxim Group | Buy → Hold |
2020-11-06 | Herabstufung | Piper Sandler | Neutral → Underweight |
Alle ansehen
Beone Medicines Ltd Adr Aktie (ONC) Neueste Nachrichten
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives $336.30 Consensus PT from Brokerages - MarketBeat
Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Upgraded at Zacks Research - Defense World
BeOne Medicines (NASDAQ:ONC) Coverage Initiated by Analysts at Barclays - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Sells 10,006 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap UpHere's What Happened - MarketBeat
BeOne Medicines (NASDAQ:ONC) Insider Sells $1,750,300.00 in Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - MarketBeat
Corazon (Corsee) D. Sanders Sells 2,665 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Finanzdaten der Beone Medicines Ltd Adr-Aktie (ONC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):